Good news! This is a bit of old news, first announced in April of this year.
"“The first malaria treatment for babies has been approved by the World Health Organization, opening the door to widespread use around the globe.
In parts of Africa, up to 18% of children under six months will be infected with malaria, but there has historically been no safe treatment for the smallest of them. ...
Medical leaders hope that Coartem Baby, which can be used to treat infants as small as 2kg (4.4lb), will fill the treatment gap. ...
enable public-sector procurement for many countries with high rates of malaria, particularly in sub-Saharan Africa.”"
"... Novartis is making the treatment available on largely not-for-profit basis in malaria-endemic regions. ..."
"... prequalification of the first treatment developed specifically for newborns and young infants weighing between two and five kilograms. ..."
Novartis malaria treatment Coartem® Baby receives WHO prequalification, paving way for greater access for newborns and young infants (original company news release)
WHO prequalifies first-ever malaria treatment for newborns and infants, adds new diagnostic tests (original WHO news release)
No comments:
Post a Comment